|
2025
|
G/S
|
Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targe... |
|
|
G/S
|
Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting ge... |
|
2024
|
Invention
|
Inhibitors of expression and/or function. The present invention relates to inhibitors, and compos... |
|
|
Invention
|
Inhibitors of expression and/or function.
The present invention relates to inhibitors, and compo... |
|
|
Invention
|
Double stranded nucleic acid compounds inhibiting zpi.
The present invention provides novel nucl... |
|
2023
|
Invention
|
Nucleic acid compounds |
|
|
Invention
|
Nucleic acid compounds. The present invention provides novel nucleic acid compounds suitable for ... |
|
|
Invention
|
Double stranded nucleic acid compounds inhibiting zpi. The present invention provides novel nucle... |
|
|
Invention
|
Nucleic acid compounds. The present invention provides novel nucleic acid compound suitable for t... |
|
|
Invention
|
Double stranded nucleic acid compounds inhibiting zpi |
|
|
Invention
|
Inhibitors of expression and/or function |
|
|
Invention
|
Conjugated oligonucleotide compounds, methods of making and uses thereof.
The present invention ... |
|
|
Invention
|
Nucleic acids containing abasic nucleotides.
The present invention relates to nucleic acid molec... |
|
2022
|
Invention
|
Nucleic acids containing abasic nucleosides. The present invention relates to nucleic acid molecu... |
|
|
G/S
|
Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutic... |
|
|
Invention
|
Conjugated oligonucleotide compounds, methods of making and uses thereof. The present invention p... |
|
|
Invention
|
Conjugated oligonucleotide compounds, methods of making and uses thereof. The present invention r... |
|
|
Invention
|
Nucleic acids containing abasic nucleotides. The present invention relates to nucleic acid molecu... |
|
2019
|
Invention
|
Method and apparatus for identifying candidate signatures and compounds for drug therapies. The p... |
|
|
Invention
|
Modulators of tryptophan catabolism.
There are described compounds of formula (I): (I) and their... |
|
|
Invention
|
Urea derivative modulators of tryptophan catabolism. There are described compounds of formula (I)... |
|
2018
|
Invention
|
Substitutes sulfonyl azacycles as modulators of hedgehog (hh) signalling pathway. There are descr... |
|
|
Invention
|
Substituted cyclyl-sulfonamides as modulators of hedgehog (hh) signalling pathway. There are desc... |
|
|
G/S
|
Medical and pharmacological research services for early stage drug discovery; early stage drug di... |
|
2017
|
Invention
|
Modulators of hedgehog (hh) signaling pathway. There are described compounds of formula (I): and ... |
|
|
Invention
|
Modulators of hedgehog (hh) signalling pathway. There are described compounds of formula (I): and... |
|
|
Invention
|
Cancer cell apoptosis.
There is described a therapeutic agent capable of directly or indirectly ... |
|
|
G/S
|
Science and technology services; medical and pharmacological research services; drug discovery se... |
|
2016
|
Invention
|
Process for the preparation of 3-substituted cannabinoid compounds. 1 is hydrogen or a protecting... |
|
|
Invention
|
Process for the preparation of 3-substituted cannabinoid compounds. There is described a method o... |
|
|
Invention
|
Cannabinoid for use in immunotherapy. There is described the use of a therapeutically effective a... |
|
2013
|
Invention
|
Tramadol for treating depression.
There is described a sub-analgesic amount of tramadol, or a sa... |
|
|
Invention
|
Tramadol for treating depression. There is described a sub-analgesic amount of tramadol, or a sal... |
|
|
Invention
|
Treatment of depression.
There is described a method of treatment of a patient suffering from de... |
